2007-April Archives by Thread

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...

Starting: Mon Apr 2 04:39:09 2007
Ending: Mon Apr 30 22:51:45 2007
Messages: 189

• [Ip-health] =?WINDOWS-1252?Q?New_York_Times:_Bush=92s_AIDS_Effort_Limited_by?= =?WINDOWS-1252?Q?_Restrictions?=   Thiru Balasubramaniam
• [Ip-health] Bloomberg: U.S. Reaches Free-Trade Agreement With South Korea   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: U.S., South Korea Reach Trade Pact   Thiru Balasubramaniam
• [Ip-health] Financial Times: US and S Korea reach landmark trade deal   Thiru Balasubramaniam
• [Ip-health] urgent: seeking IP law firm neutral to Big Pharma   Khalil Elouardighi - Act Up-Paris
• [Ip-health] Novartis Update, 2.4.07   chan park
  • [Ip-health] Novartis Update, 2.4.07   Mira Shiva
• [Ip-health] Korea Times: Trade Pact Risks Environment, Public Health   Mike Palmedo
• [Ip-health] MSF Frontline Reports: Podcast covers Access stories in Thailand and India   Buddhima Lokuge
• [Ip-health] 60 Minutes on drug lobbyists, Congress, and the Medicare drug bill,   Mike Palmedo
• [Ip-health] Senators Lieberman, Menendez, Lautenberg, Carper and Feinstein write USTR on behalf of patent owners   James Packard Love
• [Ip-health] Florida Roundtable on Global Pharmaceutical Regulation   Abbott, Frederick
• [Ip-health] Panel discussion on Facilitating Access to Affordable Medicines, April 24th at the Asia Society in New York   Rohit Malpani
• [Ip-health] Email alert: April issue of the Bulletin   bulletin
• [Ip-health] Novartis Update 3.4.07   chan park
• [Ip-health] Financial Time editorial: A tangled trade web   Thiru Balasubramaniam
• [Ip-health] IP-Watch: WHO IP Submissions Going Public; Working Paper Ready In July   Thiru Balasubramaniam
• [Ip-health] PUBPAT News: PTO Rejects Human Stem Cell Patents At Behest of Consumer Groups   Public Patent Foundation
• [Ip-health] USTR Fact Sheet on Korea FTA   Mike Palmedo
• [Ip-health] OneWorld: U.S.-Korea Trade Deal Disappoints Labor, Rights Activists   Mike Palmedo
• [Ip-health] U.S. jurisdiction in Gilead licensing matter   Sean Flynn
• [Ip-health] 12 U.S. Representatives Attack Thai CLs   Benjamin Krohmal
• [Ip-health] Obesity is dangerous, stop it   Vicky Good
• [Ip-health] I remain yours sister in Christ.   lialuta25@centrum.sk
• [Ip-health] [SYCB] The Narinjara News: 3-4 April 2007   NARINJARA NEWS
• [Ip-health] Novartis Update 4.4.07   chan park
• [Ip-health] Fed Cir. to hear challenge to DC price law TODAY   Sean Flynn
• [Ip-health] apologies for spam e-mails   Benjamin Krohmal
• [Ip-health] Oxfam: Pull Back on Stringent Intellectual Property Rules in Trade Deals Encouraging   Mike Palmedo
• [Ip-health] Reuters: U.S. trade deals raising drug prices abroad   Rohit Malpani
• [Ip-health] Cong Daily: Drug Companies Look To Head Off House Dem/Bush Deal   Mike Palmedo
• [Ip-health] USTR Report on Foreign Trade Barriers, 2007   Mike Palmedo
• [Ip-health] [korus-fta may be changed?   Sean Flynn
• [Ip-health] Request: Sign on letter from clinicians and researchers to Abbott CEO   Asia Russell
• [Ip-health] Dems on data exclusivity   Sean Flynn
• [Ip-health] Annex 2C Plus provisions in KoreaUS FTA Phrma Chapter   Sean Flynn
• [Ip-health] The Impact of University/Biotech Licensing Agreements on Access to Medicines in the Developing World   Caroline Gallant
• [Ip-health] Times of India editorial, IPR & Public Interest   msfh-india-medco-assist@field.amsterdam.msf.org
• [Ip-health] Bangkok Post: Abbott shuns Aids drug talks   Mike Palmedo
• [Ip-health] Summary of Korea-US FTA based on SKG press release   heeseob nam
• [Ip-health] E.U. compulsory licence of Shell/BASF Targor Metallocene patent rights (2000 case)   James Packard Love
• [Ip-health] E.C. on: Ethical aspects of patenting inventions involving human stem cells   James Packard Love
• [Ip-health] Public lecture recording - Dr.Thomas Faunce - Impact of US-AUS FTA on Australian PBS   Clancy Kelly
• [Ip-health] Reuters: India asks Novartis to withdraw patent challenge   chan park
• [Ip-health] Indian Govt asks novartis to withdraw patent challenge - Reuters news   msfh-india-medco-assist@field.amsterdam.msf.org
• [Ip-health] Wall Street Journal: U.S. Leaves Door to China Ajar   Thiru Balasubramaniam
• [Ip-health] Abbott cuts price of Kaletra   Benjamin Krohmal
• [Ip-health] NY Times: Congress Seeks Compromise on Generic Biologics   Mike Palmedo
• [Ip-health] WSJ editorial on generic biologics bills   Mike Palmedo
• [Ip-health] NGOs respond to Abbott $1000 Price for Aluvia   B.Baker@neu.edu
• [Ip-health] Minicurso Patentes en Foro VIH/Sida Buenos Aires   Gabriela Chaves
• [Ip-health] Minicurso Patentes en Foro VIH/Sida Buenos Aires   Gabriela Chaves
• [Ip-health] Financial Times: Malaria drug for the poor ' a bad idea'   Thiru Balasubramaniam
• [Ip-health] Letter to G4 heads of trade delegation at Delhi WTO trade talks   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Program of 15th Annual Fordham Conference: INTERNATIONAL INTELLECTUAL PROPERTY LAW & POLICY   Thiru Balasubramaniam
• [Ip-health] IHT: Thailand defies drug makers on patent issue   Judit Rius Sanjuan
• [Ip-health] Discount Price Offered for Kaletra/Aluvia - What Abbott must do next   Kannikar KIJTIWATCHAKUL
• [Ip-health] "Let Us Live and Let Them Die" ISIS on Katz   Riaz K. Tayob
• [Ip-health] Novartis case_Statement of the Indian Ambassador at the European Parliament   Alexandra HEUMBER
• [Ip-health] James Love on Lieberman's letter opposing Thai CLs   Benjamin Krohmal
• [Ip-health] Datamonitor Report: AIDS Market To Grow   Judit Rius Sanjuan
• [Ip-health] IP-Watch: Panellists Disagree About Future Of IP System, WIPO   Thiru Balasubramaniam
• [Ip-health] Abbott's Against Thailand Blackmail Continues   B.Baker@neu.edu
• [Ip-health] PIJIP Event: Shamnad Basheer on India's Patent Law 4/19   Sean Flynn
• [Ip-health] German Court invalidates drug dosage patent   James Packard Love
• [Ip-health] Maine state funded patents bill   Sean Flynn
• [Ip-health] PIJIP Event: Medicines Provisions in AUSFTA and KORUSFTA 4/18   Sean Flynn
• [Ip-health] Ottawa, April 19 -- public forum on IP and access to medicines   Richard Elliott
• [Ip-health] GPhA press release: "Lower Priced Drugs Act" to Improve Patient Access to Generic Medicines   Mike Palmedo
• [Ip-health] REMINDER: Sign on to Abbott letter from clinicians and researchers   Asia Russell
• [Ip-health] New Scientist: Making Poor Nations Pay for Drugs   Mike Palmedo
• [Ip-health] 15th WHO EML out now.   Aelaf Worku
  • [Ip-health] 15th WHO EML out now.   Caroline Gallant
    • [Ip-health] 15th WHO EML out now.   Ellen 't Hoen
• [Ip-health] Anbumani Ramadoss threatens compulsory license for Glivec   Mike Palmedo
• [Ip-health] ] Nathan, Aligning pharmaceutical innovation with medical need   Michelle Childs
• [Ip-health] Summer F/T Position- Universities Allied for Essential Medicines   Caroline Gallant
• [Ip-health] UC Berkeley & Columbia: Role of Universities & Access to Medicines   Caroline Gallant
• [Ip-health] WHO IGWG: Member States Submissions   Judit Rius Sanjuan
• [Ip-health] FromGeneva: Pre-Development Agenda Meeting In Singapore   Thiru Balasubramaniam
• [Ip-health] Thai FDA to require disclosure of production costs   ben.krohmal@keionline.org
• [Ip-health] Re: Tomorrow@WCL ~ Thomas Faunce (Australia) | Medicines Provisions of FTAs   vicki chou
• [Ip-health] Ask your Senators to vote "YES" on the Medicare Prescription Drug Price Negotiation Act   Joan Ramos
• [Ip-health] Post-Ebay Decision in D. Del.: Plaintiff Must Show Why Monetary Damages Aren't Enough   James Packard Love
• [Ip-health] Peter Zura on Toyota's $25 per car compulsory license on Paice transmission patents   James Packard Love
• [Ip-health] NEW BOOK ON THE UCAL BERKELEY / NOVARTIS DEAL   James Love
• [Ip-health] Gates Foundation Giving Poses Challenges to Pharmaceutical Industry   Joan Ramos
• [Ip-health] Economic Times: Pharma firms will have to wait a while for data exclusivity norms   Achal Prabhala
• [Ip-health] "Red tape blocking medicine for Africa" (The Globe & Mail, April 18, 2007) -- Canada reviewing legislation on compulsory licensing for export   Richard Elliott
• [Ip-health] FTC & DOJ report on patent rights and antitrust   Judit Rius Sanjuan
• [Ip-health] Kaiser News: Thailand Will Maintain Compulsory Licenses for Kaletra, Efavirenz, Despite Companies' Drug Price Reductions, Health Minister Says   Mike Palmedo
• [Ip-health] Congress Daily on possible partial fasttrack extension for Doha   Mike Palmedo
• [Ip-health] New WHO AIDS treatment progress report   Benjamin Krohmal
  • [Ip-health] New WHO AIDS treatment progress report   Benjamin Krohmal
• [Ip-health] [Fwd: Aluvia]   Wim Vandevelde
• [Ip-health] Inexpensive medicine not solution for real health-care savings   Joan Ramos
• [Ip-health] Thailand: Plans to Import Generic Aluvia   robert weissman
• [Ip-health] S Basheer on Indian Patent Act   Sean Flynn
• [Ip-health] =?windows-1258?Q?FW:_Legal_Network_Releases_13-point_Plan_to_Parliament_t?= =?windows-1258?Q?o_Fix_Canada=92s_Access_to_Medicines_Regime_/_Le_R=E9sea?= =?windows-1258?Q?u_juridique_pr=E9sente_un_plan_en_13_points_au_gouvernem?= =?windows-1258?Q?ent=2C_pour_corriger_le_R=E9gime_canadien_d=92acc=E8s_au?= =?windows-1258?Q?x_m=E9dicaments?=   Richard Elliott
• [Ip-health] Globe and Mail: Red tape blocking medicine for Africa   Thiru Balasubramaniam
• [Ip-health] =?WINDOWS-1252?Q?Asia_Sentinel:_Thailand=92s_Bittersweet_Victory?= =?WINDOWS-1252?Q?_over_Big_Pharma__?=   Thiru Balasubramaniam
• [Ip-health] The Hill (March story): House Dems scrutinize price tag of AIDS drug   Thiru Balasubramaniam
• [Ip-health] Draft report of 3rd WIPO PCDA is out   Thiru Balasubramaniam
• [Ip-health] Philippe Petit on WIPO Development Agenda at Uni of Geneva   =?ISO-8859-1?Q?Mar=EDa_Julia_Oliva?=
• [Ip-health] New CIEL IP and EPAs Publication   Dalindyebo Bafana Shabalala
• [Ip-health] WHO Press release: Partners commit to global action against forgotten diseases   Thiru Balasubramaniam
• [Ip-health] New Straits Times Online: Malaysia imposes terms on data exclusivity for US pharmaceuticals   Thiru Balasubramaniam
• [Ip-health] The Star (Malaysian paper): Rights to drugs sought   Thiru Balasubramaniam
• [Ip-health] Fwd: (Please fwd to IP Soc) April 23 ~ James Love | A New Trade Framework for Global Healthcare Research and Development   vicki chou
• [Ip-health] Malaysia data exclusivity   Sean Flynn
• [Ip-health] PIJIP Event 4/23: James Love on R&D Treaty   Sean Flynn
• [Ip-health] Tech Central Station: India - Patently Wrong   Mike Palmedo
• [Ip-health] UAEM National Day of Action   Michael Steffen
• [Ip-health] Thailand, Abbott and the Second Line AIDS Crisis: Press Teleconf Wed 25 April 2007, 10 EST   Buddhima Lokuge
• [Ip-health] MSF briefing note- Thailand, Abbott and the Second Line AIDS Crisis   Buddhima Lokuge
• [Ip-health] HT and AEI on Indian patent law   Achal Prabhala
• [Ip-health] Novartis wants drugs access overhaul   Joana Ramos
• [Ip-health] Swissinfo: Novartis wants drugs access overhaul   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Abbott's Thai Pact May Augur Pricing Shift   Thiru Balasubramaniam
• [Ip-health] Thailand, The Nation: The Eight Deadly lies of Big Pharma   B.Baker@neu.edu
• [Ip-health] Stiglitz on China: country must avoid "unbalanced IP"   James ARKINSTALL
• [Ip-health] Indian IP and Competition   Judit Rius Sanjuan
• [Ip-health] UK goverment supports TRIPS flexibilities   Judit Rius Sanjuan
• [Ip-health] LIVE WEBCAST (Today) - James Love | A New Trade Framework for Global Healthcare Research and Development   Steve D Roberts
• [Ip-health] Abbott's New Blackmail with a Smile   B.Baker@neu.edu
• [Ip-health] US envoy urges Thailand to talk with drug firms   robert weissman
• [Ip-health] The future of the medical bill (re:: Novartis cases in India)   Joana Ramos
• [Ip-health] Economic Times (India): Centre weighs Canada model for price regulation of patented drugs   Thiru Balasubramaniam
• [Ip-health] Thailand, Abbott and the Second Line AIDS Crisis: Press Teleconf Wed 25 April 2007, 10 EST   Buddhima Lokuge
• [Ip-health] Generic/Follow-On Biologics - Care to Share Your Views?   Biotech. Info. Inst.
• [Ip-health] Pharmaceutical Antitrust Speech by FTC Commissioner Rosch   James Packard Love
• [Ip-health] Literature on the Use of Patents in Public Private Partnerships   cmuban@ntlworld.com
• [Ip-health] WSJ: Harsh medicine. Thai Showdown Spotlights Threat to Drug Patents   Judit Rius Sanjuan
• [Ip-health] oh, please: Fwd: Stop the Outsourcing of US Jobs to Thailand   Ellen Shaffer
  • [Ip-health] oh, please: Fwd: Stop the Outsourcing of US Jobs to Thailand   Mike Palmedo
• [Ip-health] USA for Innovation Calls on Administration Officials to Confront Thailand's Theft of US Property   Mike Palmedo
• [Ip-health] USA for Innovation Hill Briefing: "Confronting Thailand's Theft of American Property on World IP Day"   Mike Palmedo
• [Ip-health] Vonage Wins 5.5% royalty compulsory license on Verizon Patents   James Packard Love
• [Ip-health] Abbott wrong to target Thailand   Kannikar KIJTIWATCHAKUL
• [Ip-health] Premiere Law Firm's Specious Arguments on Thailand's Compulsory Licenses   B.Baker@neu.edu
• [Ip-health] What do Democrats.com have against poor people in Thailand getting affordable medicines? | The Huffington Post]   james.love@keionline.org
• [Ip-health] Brazil takes first step for a CL on Efavirenz   Judit Rius Sanjuan
• [Ip-health] Open Letter of LAC Civil Society to LC in Thailand   gabriela@abiaids.org.br
• [Ip-health] Brazil and compulsory licenses (merck/efavirenz)   Gaelle Krikorian
• [Ip-health] Brazil declares Efavirenz to be of public interest   MSF Michel Lotrowska
• [Ip-health] NEJM: A National Survey of =?windows-1252?Q?Physician=96Industry?= =?windows-1252?Q?_Relationships?=   Ira Glazer
• [Ip-health] Bangkok Post letter: Abbott's law firm's deceptions   robert weissman
• [Ip-health] INDIANS WECOME MOVE TO OVERCOME PATENTS ON ESSENTIAL DRUGS IN THAILAND   msfh-india-medco-assist@field.amsterdam.msf.org
• [Ip-health] Associated Press: Brazil Says May Break AIDS Drug Patent   Thiru Balasubramaniam
• [Ip-health] Reuters: Court reserves order in Novartis patent case   Thiru Balasubramaniam
• [Ip-health] Tony Lopez in the Manila Times: Novartis sues India on patents   Thiru Balasubramaniam
• [Ip-health] Andrew Leonard in Salon: Democrats.com's strange neocon bedfellow   Thiru Balasubramaniam
• [Ip-health] Brazil's latest compulsory licensing announcement   James Packard Love
• [Ip-health] Q&A from the Brazilian MoH on the Efavirenz CL - official translation from the MoH available on www.aids.gov.br   MSF Michel Lotrowska
  • [Ip-health] Q&A from the Brazilian MoH on the Efavirenz CL - official translation from the MoH available on www.aids.gov.br   michael.davis@law.csuohio.edu
• [Ip-health] USA for Innovation press release on Thai ad campaign   Mike Palmedo
• [Ip-health] new note of the MoH +l Ministry of External Relations on the possible CL of Efavirenz - this one has replace the old one on the website   MSF Michel Lotrowska
• [Ip-health] PIJIP Releases Report on Thai Compulsory Licenses and Abbott's Subsequent Refusal to Register New Medicines   Mike Palmedo
• [Ip-health] =?iso-8859-1?Q?Interview_of_Jo=E3o_Sanche=2C_Communication_director_of_Me?= =?iso-8859-1?Q?rck_on_the_Brazilian_Move_towards_CL?=   MSF Michel Lotrowska
• [Ip-health] Pharmalot - Should The US Invade Thailand?   James Packard Love
• [Ip-health] Brazilian Working Group on IP - comment about declaration of public interest of efavirenz   gabriela@abiaids.org.br
• [Ip-health] UAEM Letter to Wisconsin re Abbott   Michael Steffen
• [Ip-health] More info on USA for Innovation   Michael Palmedo
• [Ip-health] BBC on Thai CLs   ben.krohmal@keionline.org
• [Ip-health] Harvard Crimson: Students Protest Drug Policy   Thiru Balasubramaniam
• [Ip-health] Bangkok Post, Specious Arguments on Thailand's Compulsory Licensing   B.Baker@neu.edu
• [Ip-health] Bridges Weekly: WHO Members Divided Over Plan For Promoting Pharmaceutical Innovation   Thiru Balasubramaniam
• [Ip-health] FW: ACT UP zaps Magic Johnson   Aaron Boyle
• [Ip-health] Crain's Chicago Busines - Abbott CEO Fights Back in Dispute Over AIDS Drug   Mike Palmedo
• [Ip-health] AIDS controversy dominates Abbott Lab's annual meeting & Students Protest Drug Policy   Sarah Rimmington
• [Ip-health] Amending Canada's law on compulsory licensing for export -- update and media coverage   Richard Elliott
• [Ip-health] Novartis buys exclusive rights to anti-smoking `vaccine`   Joana Ramos
• [Ip-health] Article about Worcester Abbott demo   Sarah Rimmington
• [Ip-health] =?WINDOWS-1252?Q?Tom_Giovanetti_in_Policy_Bytes:_Abbott=92s_"con?= =?WINDOWS-1252?Q?cession"_on_price_of_Kaletra_in_Thailand?=   Thiru Balasubramaniam
• [Ip-health] 2007 USTR 301 Report   Mike Palmedo
• [Ip-health] USTR 301 Report on compulsory licenses in Thailand   Mike Palmedo
• [Ip-health] USTR Action Against Thailand: Outrageous, Cynical, Shameful   robert weissman
• [Ip-health] KEI Statement on USTR 301 list reference to Thailand   Benjamin Krohmal
• [Ip-health] KSR v. Teleflex is in.   James Love
• [Ip-health] The Nation: Thaskin Linked to US Criticism of Government   Mike Palmedo
• [Ip-health] Cong Daily: Thailand Put On List Of Top Intellectual Property Violators ...   Mike Palmedo
• [Ip-health] Cost of Kaletra per PWA in Thailand   Sean Flynn
• [Ip-health] (SUN): Brazil: Moves on compulsory license after failed talks with drug company   Thiru Balasubramaniam
• [Ip-health] IP Watch on US Special 301 Report   Judit Rius Sanjuan
• [Ip-health] Forbes on Supreme Court Patent Ruling   Benjamin Krohmal
• [Ip-health] Thailand is elevated to Priority Watch List because of the use of TRIPs flexibilities   Kannikar KIJTIWATCHAKUL
• [Ip-health] =?WINDOWS-1252?Q?South_Korea:_Revisions_to_South_Korea=92s_IP_La?= =?WINDOWS-1252?Q?ws_In_2007?=   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] Patent Reform Act Of 2007: Bill Proposing Fundamental Changes To The Patent System   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] A person of ordinary skill not an automaton: The US Supreme court in KSR   James Packard Love

Last message date: Mon Apr 30 22:51:45 2007
Archived on: Mon Apr 30 21:51:46 2007

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...